1
|
MISHRA S, RAM S, PRASAD KK, SHARMA AK, DUTTA U, SHARMA V. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDY. Arq Gastroenterol 2022; 59:75-79. [PMID: 35442341 DOI: 10.1590/s0004-2803.202200001-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Accepted: 08/12/2021] [Indexed: 11/22/2022]
Abstract
ABSTRACT Background Procalcitonin may be increased in active ulcerative colitis (UC). We investigated the role of procalcitonin in predicting response in acute severe UC (ASUC). Methods Consecutive patients with ASUC diagnosed on basis of Truelove and Witts criteria were enrolled. Serum procalcitonin levels for consecutive patients were measured at admission and day 3. We assessed role of procalcitonin values at presentation and at day 3 in assessing response on day 3 (Oxford’s criteria) and need for second line therapy (day 28). Results Of fifty patients (23 males, mean age: 35.98±13.8 years), 16 did not respond (day 3). Ten (20%) patients required second-line therapy. Baseline procalcitonin was significantly associated with response on day 3 (P=0.016). There was no association between day 1 or day 3 procalcitonin and need for second-line rescue therapy. Conclusion Serial procalcitonin is not an effective biomarker for predicting outcomes or need for second line therapy in ASUC.
Collapse
Affiliation(s)
- Shubhra MISHRA
- Postgraduate Institute of Medical Education and Research, India
| | - Sant RAM
- Postgraduate Institute of Medical Education and Research, India
| | | | - Arun K SHARMA
- Postgraduate Institute of Medical Education and Research, India
| | - Usha DUTTA
- Postgraduate Institute of Medical Education and Research, India
| | - Vishal SHARMA
- Postgraduate Institute of Medical Education and Research, India
| |
Collapse
|